<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Zimmer Biomet Holdings Inc — News on 6ix</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc</link>
<description>Latest news and press releases for Zimmer Biomet Holdings Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 09 Apr 2026 11:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/zimmer-biomet-holdings-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835dd5678dffbe2df124ad4.webp</url>
<title>Zimmer Biomet Holdings Inc</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc</link>
</image>
<item>
<title>Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-webcast-and-conference-call-of-first-quarter-2026-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-webcast-and-conference-call-of-first-quarter-2026-financial-results</guid>
<pubDate>Thu, 09 Apr 2026 11:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its first quarter earnings conference call will be webcast on Tuesday, April 28, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.</description>
</item>
<item>
<title>Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-appoints-dr-jonathan-m-vigdorchik-as-chief-science-technology-and-medical-affairs-officer</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-appoints-dr-jonathan-m-vigdorchik-as-chief-science-technology-and-medical-affairs-officer</guid>
<pubDate>Tue, 07 Apr 2026 11:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Jonathan M. Vigdorchik, M.D., as Chief Science, Technology and Medical Affairs Officer, effective April 14.</description>
</item>
<item>
<title>Inogen Announces the Appointment of Vafa Jamali to Board of Directors</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/inogen-announces-the-appointment-of-vafa-jamali-to-board-of-directors-1</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/inogen-announces-the-appointment-of-vafa-jamali-to-board-of-directors-1</guid>
<pubDate>Mon, 06 Apr 2026 20:00:00 GMT</pubDate>
<description>BEVERLY, Mass., April 06, 2026--Inogen Announces the Appointment of Vafa Jamali to Board of Directors</description>
</item>
<item>
<title>Zimmer Biomet Wins Three Awards at Healthcare Asia Medtech Awards 2026</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-wins-three-awards-at-healthcare-asia-medtech-awards-2026</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-wins-three-awards-at-healthcare-asia-medtech-awards-2026</guid>
<pubDate>Fri, 27 Mar 2026 00:30:00 GMT</pubDate>
<description>Zimmer Biomet (NYSE and SIX: ZBH), a global medical technology leader, today announced it received three awards at the Healthcare Asia Medtech Awards 2026, recognizing the company's innovations across orthopedic product development, digital health and surgeon engagement.</description>
</item>
<item>
<title>Integral Molecular Appoints Cheryl Paes as Vice President of Commercial Strategy</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/integral-molecular-appoints-cheryl-paes-as-vice-president-of-commercial-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/integral-molecular-appoints-cheryl-paes-as-vice-president-of-commercial-strategy</guid>
<pubDate>Mon, 23 Mar 2026 13:55:00 GMT</pubDate>
<description>Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces that Cheryl Paes has joined the company as Vice President of Commercial Strategy. In this role, Paes will lead strategic initiatives to support the continued commercial growth of the company's technology platforms to serve the biotechnology and pharmaceutical industries.</description>
</item>
<item>
<title>Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-to-release-new-data-highlight-key-innovations-at-american-academy-of-orthopaedic-surgeons-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-to-release-new-data-highlight-key-innovations-at-american-academy-of-orthopaedic-surgeons-annual-meeting</guid>
<pubDate>Wed, 25 Feb 2026 12:06:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it will unveil new clinical and operational data and showcase its newest innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting. The company's Chief Movement Officer Arnold Schwarzenegger will take center stage as the conference's Presidential Guest Speaker.</description>
</item>
<item>
<title>Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-quarterly-dividend-for-first-quarter-of-2026</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-quarterly-dividend-for-first-quarter-of-2026</guid>
<pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2026. The cash dividend of $0.24 per share is payable on or about April 30, 2026 to stockholders of record as of the close of business on March 31, 2026.</description>
</item>
<item>
<title>Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-fourth-quarter-113000014</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-fourth-quarter-113000014</guid>
<pubDate>Tue, 10 Feb 2026 11:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2025. The Company reported fourth quarter net sales of $2.244 billion, an increase of 10.9% over the prior year period, an increase of 9.2% on a constant currency1 basis and an increase of 5.4% on an organic constant currency1 basis. Net sales for the full year were $8.232 billion, an increase of 7.2% over the prior year, an increase of 6.4% on a constant currency1 basis</description>
</item>
<item>
<title>Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-webcast-conference-123000531</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-webcast-conference-123000531</guid>
<pubDate>Thu, 15 Jan 2026 12:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its fourth quarter earnings conference call will be webcast on Tuesday, February 10, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.</description>
</item>
<item>
<title>Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/dentsply-sirona-appoints-mark-r-bezjak-as-group-vice-president-americas-regional-commercial-organization</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/dentsply-sirona-appoints-mark-r-bezjak-as-group-vice-president-americas-regional-commercial-organization</guid>
<pubDate>Mon, 12 Jan 2026 14:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28. The appointment supports Dentsply Sirona’s continued focus on strengthening commercial execution, deepening customer relationships and accel</description>
</item>
<item>
<title>Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-to-present-at-the-44th-annual-jp-morgan-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-to-present-at-the-44th-annual-jp-morgan-healthcare-conference</guid>
<pubDate>Mon, 22 Dec 2025 12:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PT (11:15 a.m. ET).</description>
</item>
<item>
<title>Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2025</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-quarterly-dividend-for-fourth-quarter-of-2025</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-quarterly-dividend-for-fourth-quarter-of-2025</guid>
<pubDate>Wed, 17 Dec 2025 12:00:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2025. The cash dividend of $0.24 per share is payable on or about January 30, 2026 to stockholders of record as of the close of business on December 30, 2025.</description>
</item>
<item>
<title>Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-onestep-collaborate-to-provide-enhanced-mobility-data-to-patients-and-surgeons-to-help-improve-joint-procedure-recovery</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-onestep-collaborate-to-provide-enhanced-mobility-data-to-patients-and-surgeons-to-help-improve-joint-procedure-recovery</guid>
<pubDate>Tue, 16 Dec 2025 12:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and OneStep, the FDA-listed digital fall prevention and mobility intelligence platform, today announced an exclusive collaboration agreement aimed at delivering the orthopedic industry's most comprehensive set of mobility data to further empower surgeons to track recovery progress more effectively following joint replacement surgery and enable patients to play an active role in their recovery.</description>
</item>
<item>
<title>Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-receives-us-fda-clearance-for-enhanced-version-of-rosar-knee-robotic-technology</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-receives-us-fda-clearance-for-enhanced-version-of-rosar-knee-robotic-technology</guid>
<pubDate>Fri, 14 Nov 2025 12:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ROSA® Knee with OptimiZe™, an enhanced version of its ROSA® Knee System that offers a more customized experience for surgeons to help deliver accurate and reproducible outcomes1 in robotic-assisted total knee replacement surgery.</description>
</item>
<item>
<title>Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-to-present-at-the-annual-jefferies-global-healthcare-conference-in-london</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-to-present-at-the-annual-jefferies-global-healthcare-conference-in-london</guid>
<pubDate>Fri, 07 Nov 2025 12:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, Nov. 18, 2025, at Noon GMT (7 a.m. ET).</description>
</item>
<item>
<title>Zimmer Biomet Announces Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-third-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-third-quarter-2025-financial-results</guid>
<pubDate>Wed, 05 Nov 2025 11:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2025. The Company reported third quarter net sales of $2.001 billion, an increase of 9.7% over the prior year period, an increase of 8.6% on a constant currency1 basis and an increase of 5.0% on an organic constant currency1 basis. Net earnings for the third quarter were $230.9 million, or $377.0 million on an adjusted1 basis.</description>
</item>
<item>
<title>Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-fda-breakthrough-designation-for-worlds-first-iodine-treated-total-hip-replacement-system</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-announces-fda-breakthrough-designation-for-worlds-first-iodine-treated-total-hip-replacement-system</guid>
<pubDate>Tue, 28 Oct 2025 11:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company's first-to-world iodine-treated total hip replacement system. This is the first product in Zimmer Biomet history to receive this designation.</description>
</item>
<item>
<title>Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-highlights-robotics-and-musculoskeletal-product-innovations-at-2025-aahks-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-highlights-robotics-and-musculoskeletal-product-innovations-at-2025-aahks-annual-meeting</guid>
<pubDate>Tue, 21 Oct 2025 11:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting bold innovations across its broad robotics and musculoskeletal portfolio at the 2025 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS).</description>
</item>
<item>
<title>Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-launches-two-new-foot-and-ankle-solutions-for-complex-trauma-cases</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-launches-two-new-foot-and-ankle-solutions-for-complex-trauma-cases</guid>
<pubDate>Wed, 08 Oct 2025 11:30:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, a wholly owned subsidiary, today announced the full commercial launch of two innovative solutions for complex foot and ankle trauma to offer surgeons advanced tools to address challenging pilon fractures and hindfoot injuries with precision and efficiency.</description>
</item>
<item>
<title>Zimmer Biomet Completes Acquisition of Monogram Technologies</title>
<link>https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-completes-acquisition-of-monogram-technologies</link>
<guid isPermaLink="true">https://6ix.com/company/zimmer-biomet-holdings-inc/news/zimmer-biomet-completes-acquisition-of-monogram-technologies</guid>
<pubDate>Tue, 07 Oct 2025 13:00:00 GMT</pubDate>
<description>Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ("Zimmer Biomet"), a global medical technology leader, today announced it has completed the acquisition of Monogram Technologies Inc. ("Monogram"), an AI-driven, next-generation orthopedic robotics company.</description>
</item>
</channel>
</rss>